— Know what they know.
Not Investment Advice

AMRI NASDAQ

Albany Molecular Research, Inc.
1W: +0.1% 1M: +0.1% 3M: +7.8% 1Y: +46.7% 3Y: +12.6% 5Y: +550.9%
$21.74
Last traded 2017-08-31 — delisted
NASDAQ · Healthcare · Biotechnology

📊 Key Metrics

TTM
$681M
Revenue
+48.9% YoY
$-60M
Net Income
-77.3% YoY
$-17M
Free Cash Flow
-269.6% YoY
23.8%
Gross Margin
-0.9%
Op. Margin
-5.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-20.6%
ROA-5.8%
ROIC-1.8%

Valuation

P/E-13.2
P/B3.1
EV/EBITDA25.4

Leverage

Debt/Equity1.98
Current Ratio0.68
Interest Cov.-0.3x

Quality Scores

Piotroski F3/9
Altman Z0.90
Beneish M-2.15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms